Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Melanoma is a significant skin cancer with complex genetic underpinnings.
• Fibroblast growth factor receptor 2 (FGFR2) is a receptor tyrosine kinase implicated in various cellular processes.
• The role of FGFR2 in melanoma, particularly loss-of-function mutations, remains largely unexplored.

Purpose of the Study:

• To investigate the frequency and nature of fibroblast growth factor receptor 2 (FGFR2) gene mutations in melanoma.
• To determine the functional consequences of identified FGFR2 mutations in melanoma.
• To explore the potential context-dependent roles of FGFR2 in cancer development.

Main Methods:

• Analysis of FGFR2 gene mutations in melanoma tumors and cell lines.
• Structural mapping of mutations onto FGFR2 crystal structures.
• In vitro and in vivo functional assays to assess receptor activity.

Main Results:

• Approximately 10% of melanoma samples harbor novel FGFR2 mutations, including truncating and missense variants.
• The mutation spectrum suggests UV radiation as a causative factor.
• Identified mutations lead to loss of FGFR2 function via impaired ligand binding, dimerization, stability, and kinase activity.

Conclusions:

• This study demonstrates, for the first time, loss-of-function mutations in the class IV receptor tyrosine kinase FGFR2 in cancer.
• FGFR2 mutations in melanoma are associated with UV damage and lead to impaired receptor function.
• FGFR2 exhibits context-dependent opposing roles in cancer, with loss-of-function in melanoma and potential activation in endometrial cancer.